Worldquant Millennium Advisors LLC Buys 310,119 Shares of Colgate-Palmolive (NYSE:CL)

Worldquant Millennium Advisors LLC increased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 63.9% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 795,100 shares of the company's stock after purchasing an additional 310,119 shares during the period. Worldquant Millennium Advisors LLC owned approximately 0.10% of Colgate-Palmolive worth $82,539,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Continuum Advisory LLC lifted its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive in the 3rd quarter worth $53,000. Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive in the third quarter valued at about $64,000. Finally, Gradient Investments LLC raised its stake in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Wells Fargo & Company cut their target price on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research note on Monday, October 28th. UBS Group increased their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. TD Cowen reduced their target price on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Stock Down 0.9 %

Shares of NYSE:CL traded down $0.87 on Friday, hitting $94.23. 3,990,483 shares of the company traded hands, compared to its average volume of 4,382,668. The stock has a 50 day simple moving average of $96.73 and a 200-day simple moving average of $98.61. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a market cap of $76.99 billion, a PE ratio of 27.00, a PEG ratio of 3.38 and a beta of 0.43. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.12%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.34% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.